Dhampur BioQ2 FY25

Dhampur Bio Q2 FY25 Earnings Call Analysis

Revenue, margin, capex, fundraise and order book outlook from management commentary.

Price: ₹146.28P/E: 38.0Market Cap: ₹971 CrSector: Agricultural Food & other Products

Management growth scorecard

Revenue

Category 4

Margin

Category 4

Fundraise

No

Order

N/A

Capex

No

0 of 4 growth signals are positive — mixed outlook.

Full analysis

Revenue guidance

Category 4
  • Sugar sales volumes increased by 5% YoY in Q2 FY25; focus on institutional sales is driving better pricing and volumes.
  • Efforts underway to increase sugar sales in non-traditional, non-Asian segments from 25% currently to 60-70% over the next 2 years.
  • Ethanol supply for the current season is expected at around 6.5 kilo liters versus about 3-4.5 kilo liters last season, indicating growth in ethanol volumes.
  • Grain ethanol capacity utilization expected to improve as remaining plants commence production, with flexibility to participate in future ethanol tenders.
  • Country liquor segment shows steady volume growth, necessitating marginal capex to increase bottling capacity.
  • Management expects no major capex in sugar capacity but will focus on value addition initiatives to boost realization.
  • Overall, company aims for volume growth across sugar, ethanol, and liquor segments while enhancing realization via premiumization and efficiency improvements.

See what Dhampur Bio management said on margin guidance — free account, 30 seconds.

Fundraise plans

No
  • No explicit mention of new fundraising through debt or equity in the call transcript.
  • Current long-term loan stands at INR239 crores as of 30th September 2024, with a comfortable debt equity ratio of 0.24.
  • The company has been repaying long-term loans (around INR34 crores repaid during first half).
  • Interest cost has increased due to higher inventory and deployment of internal accruals towards capex.
  • Management emphasizes maintaining a strong and healthy balance sheet.
  • No indication of plans for fresh debt or equity issue; focus is on utilizing internal accruals and managing existing loans.
  • Future initiatives and capex are planned within existing financial structures; any major capex decisions deferred based on market conditions.

See what Dhampur Bio management said on order book — free account, 30 seconds.

Capex plans

No
  • No major capex or capacity enhancement plans for sugar segment in the foreseeable future; focus remains on value addition and efficiency improvements.
  • Marginal capex planned for increasing bottling capacity in country liquor segment due to steady volume growth; these are nominal and not substantial.
  • Grain-based ethanol facility capex of around INR 94 crores (INR 48 crores grain-based, rest normal) is ongoing with capitalization expected soon.
  • Interest subvention available on grain-based ethanol capex with approximately INR 40 crores loans qualifying for 50% interest support.
  • Plant commissioning for grain-based ethanol expected before end of year; tender-related bidding may happen once operational.
  • Management and board continuously review options including buyback/dividend if surplus cash and no material reinvestment needs arise.
  • No immediate plans for further large-scale capital investments; focus on maintaining healthy balance sheet and sustainable growth.

Track Dhampur Bio — get its next earnings analysis in your feed

How does Dhampur Bio rank vs peers in Agricultural Food & other Products?

Pro feature
ThisDhampur Bio
Rev 4Mar 4

How does Dhampur Bio rank in Agricultural Food & other Products?

Compare Dhampur Bio against every Agricultural Food & other Products company (Q2 FY25) on revenue, margins and earnings-call signals.

View Agricultural Food & other Products leaderboard →

Others in Agricultural Food & other Products this season

  • M.V.K. Agro (Q2 FY27)

    For the quarter ended September 30, 2026, MVK Agro Food Product Ltd reported revenue from operations of ₹6,145.91 lakhs, up from ₹4,215.70 lakhs in the same…

  • Gokul Refoils (Q2 FY27)

    17,449.65 lakhs (approximately 16.4% growth) . Key results statement takeaways from Gokul Refoils and Solvent Ltd's Q2 FY27 results statement — and how it ranks

  • Patanjali Foods (Q2 FY27)

    11,322.58 crores, up 15.55% YoY. Key results statement takeaways from Patanjali Foods Ltd's Q2 FY27 results statement — and how it ranks against sector peers.

  • GRM Overseas (Q2 FY27)

    Q2 FY27 Revenue from Operations: ₹452.6 Cr, up 22% YoY from ₹372.4 Cr in Q2 FY26 (Page 8) . Key investor presentation takeaways from GRM Overseas Ltd's Q2 FY27

🔎 Who's planning the most growth?

Companies ranked by management's own guidance — revenue, margins, capex and order book, from every earnings call in India.

See rankings →